Susquehanna International Group, LLP Adma Biologics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$11.21 - $20.03 $373,293 - $666,999	33,300 Added 333.0%	43,300 $865,000
Q2 2024 Aug 15, 2024	BUY	$5.98 - $11.18 $59,800 - $111,800	10,000 New	10,000 $111,000
Q3 2023 Nov 14, 2023	SELL	$3.47 - $4.61 $47,886 - $63,618	-13,800 Reduced 42.46%	18,700 $66,000
Q2 2023 Aug 11, 2023	SELL	$3.12 - $4.22 $8,424 - $11,394	-2,700 Reduced 7.67%	32,500 $119,000
Q1 2023 May 16, 2023	SELL	$3.01 - $3.87 $89,999 - $115,713	-29,900 Reduced 45.93%	35,200 $116,000
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $73,853 - $116,012	-29,900 Reduced 31.47%	65,100 $252,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $33,698 - $47,476	16,600 Added 21.17%	95,000 $231,000

317

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.74B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.